Global /Taiwan /Healthcare /Medical Devices /4183
chevron_leftBack
EPS Bio Technology Corp. logo

EPS Bio Technology Corp.

4183
TPEX: 4183 Delayed
14.35TWD 1.8%
0.4535 USD
As of 20 June 2026, EPS Bio Technology Corp. has a market cap of $10.61M USD, ranking #41003 globally and #2321 in Taiwan. It ranks #3646 in the Healthcare sector, and #769 in the Medical Devices industry.
Global Rank
41003
Country Rank
2321
Sector Rank
3646
Industry Rank
769
Key Stats
Market Cap
$10.61MUSD
335.58M TWD
Enterprise Value
$11.08MUSD
350.61M TWD
Revenue (TTM)
$15.8MUSD
499.7M TWD
EBITDA (TTM)
$198.71KUSD
6.29M TWD
Net Income (TTM)
-$248.75KUSD
-7.87M TWD
EBITDA Margin
1.3%
Profit Margin
-1.6%
PS Ratio
0.7
PB Ratio
1.2
EV/EBITDA
55.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Cheng-Hui Cho open_in_new
Employees
109
Founded
2006
Website
epsbio.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.8% -7.5% -12% -13% -22% -31%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
4183
福永生物科技股份有限公司
ISIN: TW0004183009
Shares Out.:
23.8M1
TV:
SA:
YF:
GF:
BA:
MS:
14.35 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About EPS Bio Technology Corp.

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)
Name
Market Cap diff.
PE
$667.4M
21.1B TWD
6K%
29.1
$377.01M
11.92B TWD
3K%
8.3
$301.92M
9.55B TWD
3K%
17.5
4107
$254.21M
8.04B TWD
2K%
15.0
1788
$190.77M
6.03B TWD
2K%
16.4
$184.81M
5.84B TWD
2K%
15.2
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
2M%
25.8
$160.73B
2M%
56.7
$159.07B
1M%
25.6
DHR
$126.55B
1M%
34.7
SYK
$120.69B
1M%
38.3
MDT
$101.9B
960K%
22.2
chevron_leftBack